Cargando…

Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils

Interferons (IFNs) are induced by viruses and are the main regulators of the host antiviral response. They balance tissue tolerance and immune resistance against viral challenges. Like all cells in the human body, neutrophils possess the receptors for IFNs and contribute to antiviral host defense. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Stegelmeier, Ashley A., Darzianiazizi, Maedeh, Hanada, Kiersten, Sharif, Shayan, Wootton, Sarah K., Bridle, Byram W., Karimi, Khalil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125486/
https://www.ncbi.nlm.nih.gov/pubmed/33946935
http://dx.doi.org/10.3390/ijms22094726
_version_ 1783693517256654848
author Stegelmeier, Ashley A.
Darzianiazizi, Maedeh
Hanada, Kiersten
Sharif, Shayan
Wootton, Sarah K.
Bridle, Byram W.
Karimi, Khalil
author_facet Stegelmeier, Ashley A.
Darzianiazizi, Maedeh
Hanada, Kiersten
Sharif, Shayan
Wootton, Sarah K.
Bridle, Byram W.
Karimi, Khalil
author_sort Stegelmeier, Ashley A.
collection PubMed
description Interferons (IFNs) are induced by viruses and are the main regulators of the host antiviral response. They balance tissue tolerance and immune resistance against viral challenges. Like all cells in the human body, neutrophils possess the receptors for IFNs and contribute to antiviral host defense. To combat viruses, neutrophils utilize various mechanisms, such as viral sensing, neutrophil extracellular trap formation, and antigen presentation. These mechanisms have also been linked to tissue damage during viral infection and inflammation. In this review, we presented evidence that a complex cross-regulatory talk between IFNs and neutrophils initiates appropriate antiviral immune responses and regulates them to minimize tissue damage. We also explored recent exciting research elucidating the interactions between IFNs, neutrophils, and severe acute respiratory syndrome-coronavirus-2, as an example of neutrophil and IFN cross-regulatory talk. Dissecting the IFN-neutrophil paradigm is needed for well-balanced antiviral therapeutics and development of novel treatments against many major epidemic or pandemic viral infections, including the ongoing pandemic of the coronavirus disease that emerged in 2019.
format Online
Article
Text
id pubmed-8125486
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81254862021-05-17 Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils Stegelmeier, Ashley A. Darzianiazizi, Maedeh Hanada, Kiersten Sharif, Shayan Wootton, Sarah K. Bridle, Byram W. Karimi, Khalil Int J Mol Sci Review Interferons (IFNs) are induced by viruses and are the main regulators of the host antiviral response. They balance tissue tolerance and immune resistance against viral challenges. Like all cells in the human body, neutrophils possess the receptors for IFNs and contribute to antiviral host defense. To combat viruses, neutrophils utilize various mechanisms, such as viral sensing, neutrophil extracellular trap formation, and antigen presentation. These mechanisms have also been linked to tissue damage during viral infection and inflammation. In this review, we presented evidence that a complex cross-regulatory talk between IFNs and neutrophils initiates appropriate antiviral immune responses and regulates them to minimize tissue damage. We also explored recent exciting research elucidating the interactions between IFNs, neutrophils, and severe acute respiratory syndrome-coronavirus-2, as an example of neutrophil and IFN cross-regulatory talk. Dissecting the IFN-neutrophil paradigm is needed for well-balanced antiviral therapeutics and development of novel treatments against many major epidemic or pandemic viral infections, including the ongoing pandemic of the coronavirus disease that emerged in 2019. MDPI 2021-04-29 /pmc/articles/PMC8125486/ /pubmed/33946935 http://dx.doi.org/10.3390/ijms22094726 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Stegelmeier, Ashley A.
Darzianiazizi, Maedeh
Hanada, Kiersten
Sharif, Shayan
Wootton, Sarah K.
Bridle, Byram W.
Karimi, Khalil
Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
title Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
title_full Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
title_fullStr Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
title_full_unstemmed Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
title_short Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
title_sort type i interferon-mediated regulation of antiviral capabilities of neutrophils
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125486/
https://www.ncbi.nlm.nih.gov/pubmed/33946935
http://dx.doi.org/10.3390/ijms22094726
work_keys_str_mv AT stegelmeierashleya typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils
AT darzianiazizimaedeh typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils
AT hanadakiersten typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils
AT sharifshayan typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils
AT woottonsarahk typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils
AT bridlebyramw typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils
AT karimikhalil typeiinterferonmediatedregulationofantiviralcapabilitiesofneutrophils